BAVA Bavarian Nordic A/S

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

COPENHAGEN, Denmark, October 29, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.20% of the shares and voting rights in Bavarian Nordic A/S as of October 23, 2025.

About Bavarian Nordic

Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit .

Contact investors:

Europe: Disa Tuominen, IR Manager,

US: Graham Morrell, Gilmartin Group, , Tel:

Contact media:

Nicole Seroff, Vice President Corporate Communications, , Tel:

Company Announcement no. 34 / 2025

Attachment



EN
29/10/2025

Underlying

BAVABavarian Nordic A/S

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bavarian Nordic A/S

 PRESS RELEASE
Free
BAVA Bavarian Nordic...

Bavarian Nordic offentliggør storaktionærmeddelelse fra Morgan Stanley

Bavarian Nordic offentliggør storaktionærmeddelelse fra Morgan Stanley KØBENHAVN, Danmark, 31. oktober 2025 – I henhold til §30 i Lov om kapitalmarkeder, meddeler Bavarian Nordic A/S hermed, at selskabet har modtaget meddelelse fra Morgan Stanley om, at de pr. 27. oktober 2025 besidder 4.99% af aktierne og stemmerettighederne i Bavarian Nordic A/S. Om Bavarian NordicBavarian Nordic er et globalt vaccineselskab med en mission om at forbedre sundheden og redde liv gennem innovative vacciner. Vi er en foretrukken leverandør af mpox- og koppevacciner til regeringer med hensyn til at forbedre ...

4h / 47m 1 EN
 PRESS RELEASE
Free
BAVA Bavarian Nordic...

Bavarian Nordic Announces Major Shareholder Notification from Morgan S...

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley COPENHAGEN, Denmark, October 31, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4.99% of the shares and voting rights in Bavarian Nordic A/S as of October 27, 2025. About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to en...

4h / 47m 1 EN
 PRESS RELEASE
Free
BAVA Bavarian Nordic...

Bavarian Nordic aktionærer påmindes om udløbet af tilbudsperioden vedr...

Bavarian Nordic aktionærer påmindes om udløbet af tilbudsperioden vedrørende overtagelsestilbuddet fra konsortium bestående af Nordic Capital og Permira MÅ IKKE UDGIVES, OFFENTLIGGØRES ELLER DISTRIBUERES, DIREKTE ELLER INDIREKTE, I ELLER TIL NOGEN JURISDIKTION, HVOR DETTE VILLE UDGØRE EN OVERTRÆDELSE AF DE RELEVANTE LOVE ELLER FORORDNINGER I DEN PÅGÆLDENDE JURISDIKTION København, Danmark, 31 oktober, 2025 – Der henvises til selskabsmeddelelserne af 26. august 2025 (nr. 24/2025), 29. september 2025 (nr. 27/2025), 15. oktober 2025 (nr. 31/2025) og 21. oktober 2025 (nr. 33/2025) vedrørende de...

6h / 37m 1 EN
 PRESS RELEASE
Free
BAVA Bavarian Nordic...

Bavarian Nordic shareholders are reminded of expiry of the offer perio...

Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, 31 October, 2025 – Reference is made to the company announcements dated 26 August 2025 (no. 24/2025), 29 September 2025 (no. 27/2025), 15 October 2025 (no. 31/2025), and 21 October 2025 (no. 33/2025) regarding the all-c...

6h / 37m 1 EN
 PRESS RELEASE
Free
BAVA Bavarian Nordic...

Bavarian Nordic opnår ny rammeaftale med Europa-Kommissionen med henbl...

Bavarian Nordic opnår ny rammeaftale med Europa-Kommissionen med henblik på styrkelse af beredskabet mod kopper og mpox Ny og større rammeaftale med Europa-Kommissionens Myndighed for Kriseberedskab og ‑indsats på Sundhedsområdet (HERA) erstatter tidligere aftale og omfatter op til 8 millioner doser af koppe-/mpoxvaccinen over de næste fire år.Yderligere lande har tiltrådt aftalen, som nu giver adgang til vaccinen for 20 EU-medlemslande og andre europæiske lande. KØBENHAVN, Danmark, 31. oktober 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har fået tildelt en fælles ...

11h / 29m 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch